Concord Financial Statements From 2010 to 2024

CCM Stock  USD 0.59  0.02  3.28%   
Concord Medical financial statements provide useful quarterly and yearly information to potential Concord Medical Services investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Concord Medical financial statements helps investors assess Concord Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Concord Medical's valuation are summarized below:
Gross Profit
-152.4 M
Profit Margin
(0.76)
Market Capitalization
26 M
Enterprise Value Revenue
0.7228
Revenue
612.3 M
There are over one hundred nineteen available fundamental signals for Concord Medical Services, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Concord Medical's prevailing fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord main balance sheet or income statement drivers, such as Interest Expense of 145.3 M, Selling General Administrative of 375.7 M or Total Revenue of 431.6 M, as well as many exotic indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.14 or Operating Cycle of 250. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
  
This module can also supplement various Concord Medical Technical models . Check out the analysis of Concord Medical Correlation against competitors.

Concord Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.8 B6.9 BB
Slightly volatile
Other Current Liabilities273.9 M374 M284.7 M
Slightly volatile
Total Current Liabilities733.9 M1.3 B805.7 M
Slightly volatile
Other Liabilities324.7 M309.2 M150.4 M
Slightly volatile
Cash256 M142.5 M239.3 M
Very volatile
Other Assets26.2 M27.6 M321.9 M
Very volatile
Long Term DebtB2.9 B1.1 B
Slightly volatile
Common Stock Shares Outstanding46.9 M50.2 M45.8 M
Slightly volatile
Other Current Assets20.8 M21.8 M103.2 M
Pretty Stable
Total Liabilities4.8 B4.6 B2.3 B
Slightly volatile
Intangible Assets920.2 M876.4 M478.2 M
Slightly volatile
Common Stock105.4 K120.8 K99.4 K
Slightly volatile
Property Plant Equipment4.7 B4.4 B1.8 B
Slightly volatile
Short and Long Term Debt Total3.9 B3.7 B1.7 B
Slightly volatile
Property Plant And Equipment Net4.2 BBB
Slightly volatile
Current Deferred Revenue121.7 M115.9 M42.3 M
Slightly volatile
Accounts Payable177.2 M168.8 M54.2 M
Slightly volatile
Non Current Assets TotalBB3.2 B
Slightly volatile
Non Currrent Assets Other19.8 M20.9 M287.5 M
Slightly volatile
Cash And Short Term Investments278.7 M142.5 M271.4 M
Pretty Stable
Net Receivables326.1 M589.7 M338.9 M
Slightly volatile
Common Stock Total Equity111.2 K120.8 K103.1 K
Slightly volatile
Liabilities And Stockholders Equity4.1 B6.9 B4.1 B
Slightly volatile
Non Current Liabilities Total3.5 B3.3 B1.5 B
Slightly volatile
Other Stockholder Equity1.7 B1.7 B1.9 B
Slightly volatile
Property Plant And Equipment Gross4.6 B4.3 B2.1 B
Slightly volatile
Total Current Assets758 M683.8 M902.3 M
Pretty Stable
Short Term Debt451.4 M630.8 M469.3 M
Very volatile
Short Term Investments2.3 M2.4 M48.5 M
Slightly volatile
Deferred Long Term Liabilities1.5 MM1.4 M
Slightly volatile
Long Term Investments308 M503.6 M284.2 M
Slightly volatile
Short and Long Term Debt346.9 M461.3 M560.2 M
Slightly volatile
Long Term Debt Total2.6 B2.5 B984.6 M
Slightly volatile
Capital Surpluse1.8 B2.2 B1.2 B
Slightly volatile
Cash And Equivalents230.8 M181 M197.8 M
Very volatile
Net Invested Capital1.2 BB1.7 B
Slightly volatile
Capital Stock84 K94.5 K102.9 K
Slightly volatile

Concord Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative375.7 M357.8 M211.5 M
Slightly volatile
Total Revenue431.6 M542.9 M426.6 M
Pretty Stable
Cost Of Revenue754.1 M718.2 M342.3 M
Slightly volatile
Selling And Marketing Expenses52.5 M70.7 M54.3 M
Very volatile
Other Operating Expenses1.2 B1.1 B613.1 M
Slightly volatile
Total Operating Expenses239.2 M428.5 M253.7 M
Slightly volatile
Minority Interest305.2 M321.2 M606 M
Slightly volatile
Interest Income8.6 MM16.6 M
Very volatile
Reconciled Depreciation95.9 M152.7 M95.6 M
Pretty Stable

Concord Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Cashflows From Financing Activities997.2 M894.3 MB
Slightly volatile
Capital Expenditures296.3 M442.5 M320 M
Slightly volatile
End Period Cash Flow136.2 M143.4 M273.5 M
Very volatile
Begin Period Cash Flow135.9 M143 M292.2 M
Pretty Stable
Depreciation88.9 M119.5 M112.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.141.22.7696
Slightly volatile
Dividend Yield0.140.190.1901
Pretty Stable
Operating Cycle250401336
Slightly volatile
Days Of Payables Outstanding10498.6447.3228
Pretty Stable
Inventory Turnover8.048.4732.6355
Pretty Stable
Payables Turnover4.654.8970.68
Pretty Stable
Long Term Debt To Capitalization3.072.931.0781
Slightly volatile
Cash Per Share3.964.177.0926
Slightly volatile
Total Debt To Capitalization2.232.120.9807
Slightly volatile
Quick Ratio0.650.690.9835
Slightly volatile
Net Income Per E B T1.480.821.9029
Very volatile
Cash Ratio0.150.160.4395
Slightly volatile
Cash Conversion Cycle219324295
Slightly volatile
Days Of Inventory Outstanding30.6157.0238.7529
Slightly volatile
Days Of Sales Outstanding232357309
Slightly volatile
Current Ratio0.740.781.289
Slightly volatile
Fixed Asset Turnover0.150.160.3597
Slightly volatile
Debt Ratio0.510.490.346
Slightly volatile
Price Sales Ratio1.141.22.7696
Slightly volatile
Receivables Turnover1.711.061.4076
Slightly volatile
Asset Turnover0.140.09040.1237
Slightly volatile

Concord Fundamental Market Drivers

Cash And Short Term Investments158.3 M

Concord Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Concord Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Concord Medical income statement, its balance sheet, and the statement of cash flows. Concord Medical investors use historical funamental indicators, such as Concord Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Concord Medical investors may use each financial statement separately, they are all related. The changes in Concord Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Concord Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Concord Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Concord Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue115.9 M121.7 M
Total Revenue542.9 M431.6 M
Cost Of Revenue718.2 M754.1 M
Ebit Per Revenue(1.28)(1.22)

Pair Trading with Concord Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Concord Stock

  0.88BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.88PNTG Pennant Group Financial Report 2nd of May 2024 PairCorr
  0.86EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.85MDWD Mediwound Downward RallyPairCorr
  0.73COO Cooper Companies Financial Report 6th of June 2024 PairCorr
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out the analysis of Concord Medical Correlation against competitors.
Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.48)
Revenue Per Share
14.017
Quarterly Revenue Growth
0.972
Return On Assets
(0.05)
Return On Equity
(0.31)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.